Advertisement

A Pilot Study on Assessment of Triplet Repeat Primed PCR for Fragile X Syndrome Diagnosis

  • Srinivasan Muthuswamy
  • Deepika D Dean
  • Sarita Agarwal
Chapter
Part of the SpringerBriefs in Applied Sciences and Technology book series (BRIEFSAPPLSCIENCES)

Abstract

FMR1 gene contains a stretch of CGG repeat that usually remains less than 45 in healthy subjects. However when goes beyond 200, it results in developmental delay or mental retardation called fragile X syndrome (FXS). The repeat number between 56 and 200 are reported to be associated with fragile X associated tremor/ataxia syndrome and primary ovarian failure. Therefore the number of CGG repeat at FMR1 gene (5’UTR) determines the nature of disease. Though, there are multiple molecular methods are available for FXS diagnosis, TP-PCR is more rapid and straightforward in providing diagnosis. Thus, present study was aimed to assess the diagnostic applicability of TP-PCR optimized in our lab. The diagnosis was made on 20 samples and results of the present study were found to be concordant with diagnosis made from other lab. Our method can differentiate normal, premutation and full mutation alleles. Accurate sizing is possible for normal and premutation range. We conclude that our method is cost effective, rapid and accurate in diagnosis of FXS cases as well as premutation carriers.

Keywords

Fragile X syndrome Developmental delay Mental retardation Triplet repeat primed PCR 

Notes

Acknowledgments

We would like to thank Dr. Samuel S. Chong for providing technical support and Dr. Ashwin R Dalal for sharing his samples with us.

References

  1. 1.
    Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA (2007) Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol 6:45–55CrossRefGoogle Scholar
  2. 2.
    Hagerman RJ, Hagerman PJ (2002) The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev 12:278–283CrossRefGoogle Scholar
  3. 3.
    Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127–130CrossRefGoogle Scholar
  4. 4.
    Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL (2005) Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20:402–412CrossRefGoogle Scholar
  5. 5.
    Willemsen R, Smits A, Severijnen LA, Jansen M, Jacobs A, De BE, Oostra B (2003) Predictive testing for cognitive functioning in female carriers of the fragile X syndrome using hair root analysis. J Med Genet 40:377–379CrossRefGoogle Scholar
  6. 6.
    Turner G, Webb T, Wake S, Robinson H (1996) Prevalence of fragile X syndrome. Am J Med Genet 64:196–197CrossRefGoogle Scholar
  7. 7.
    Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM (2007) The FMR1 premutation and reproduction. Fertil Steril 87:456–465CrossRefGoogle Scholar
  8. 8.
    Sherman SL (2000) Premature ovarian failure in the fragile X syndrome. Am J Med Genet 97:189–194CrossRefGoogle Scholar
  9. 9.
    Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817–822CrossRefGoogle Scholar
  10. 10.
    Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RG Jr, Warren ST et al (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047–1058CrossRefGoogle Scholar
  11. 11.
    Sutherland GR (1977) Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science 197:265–266CrossRefGoogle Scholar
  12. 12.
    Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Boue J, Tommerup N, Van Der Hagen C, Delozier-Blanchet C, Croquette MF et al (1991) Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 325:1673–1681CrossRefGoogle Scholar
  13. 13.
    Willemsen R, Mohkamsing S, de VB, Devys D, van den Ouweland A, Mandel JL, Galjaard H, Oostra B (1995) Rapid antibody test for fragile X syndrome. Lancet 345:1147–1148Google Scholar
  14. 14.
    Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, Zhang W, Hagerman PJ, Stenzel TT, Hadd AG, Latham GJ et al (2010) A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 56:399–408Google Scholar
  15. 15.
    Lyon E, Laver T, Yu P, Jama M, Young K, Zoccoli M, Marlowe N (2010) A simple, high-throughput assay for Fragile X expanded alleles using triple repeat primed PCR and capillary electrophoresis. J Mol Diagn 12:505–511CrossRefGoogle Scholar
  16. 16.
    Zhou Y, Lum JM, Yeo GH, Kiing J, Tay SK, Chong SS (2006) Simplified molecular diagnosis of fragile X syndrome by fluorescent methylation-specific PCR and GeneScan analysis. Clin Chem 52:1492–1500CrossRefGoogle Scholar

Copyright information

© The Author(s) 2016

Authors and Affiliations

  • Srinivasan Muthuswamy
    • 1
  • Deepika D Dean
    • 1
  • Sarita Agarwal
    • 1
  1. 1.Department of Medical GeneticsSanjay Gandi Postgraduate Institute of Medical SciencesLucknowIndia

Personalised recommendations